BioCell Technology has introduced BioCell Collagen Extra Refined Palatable (ERP), a functional ingredient specifically designed for sensory formats.
This new format contains the same matrix of hydrolysed collagen type II peptides, hyaluronic acid and chrondroitin sulfate contained in the original formulation, but with an improved texture and neutral taste.
The novel nutraceutical can be incorporated into a range of popular delivery formats, including gummies, chewables and lozenges.
"We are introducing BioCell Collagen ERP to support our customers seeking to reach consumers who prefer taking supplements in a non-pill format," said Mo Ishaq, CEO of BioCell Technology LLC. "
We've invested in an advanced refining process that delivers BioCell Collagen ERP as a fine white to off-white powder with a natural and neutral taste that can support a range of wide product flavours without interfering in the intended product taste."
According to BioCell Technology, its collagen ingredient is one of the few functional ingredients on the market that can prevent the degradation of connective tissue, which could be particularly useful in a healthy ageing-focused supplement formulation.
The ingredient has also been proven to support skin health by combatting wrinkles and fine lines, suggesting its potential in the beauty from within sector.
The potential of matrix ingredients
There are many collagen ingredients coming into the market currently, but BioCell Technology believes that BioCell Collagen stands out owing to its matrix formulation.
This matrix is designed to enhance the absorbability and bioavailability of each ingredient, potentially increasing the formulation's overall efficacy.
BioCell Technology's announcement comes at a time when collagen is becoming a key purchase motivation point for consumers.
"Our new research shows that skin health continues to be a priority for consumers to purchase and take dietary supplements – that places collagen as a leading ingredient on a top health concern that motivates consumers to engage with the supplement market," said Len Monheit, chief executive officer of the Collagen Stewardship Alliance, part of the Industry Transparency Center, which issued their 2024 Insights on Collagen Users in June.
"Our 2024 survey also shows that joint health and concerns over joint discomfort has moved up as a top health concern motivator for supplement purchase," said Monheit.
"New Collagen Stewardship Alliance data shows that consumers are highly motivated to engage with supplements for skin health and joint mobility concerns. This data may indicate an evolution in consumer behavior, especially for joint health," said Mo.
"A new generation of adults who are taking a proactive approach to their wellness may be looking more to the proven benefits of collagen for joint health. It's worth exploring new ways to serve their growing interest."
